Dr Mitchell Glass to speak at breakfast presentation: Drugs & diagnostics – navigating the FDA approval chain

Zernicke Australia is hosting a special breakfast event on Thursday 21 November 2013 entitled: Drugs & diagnostics – navigating the FDA approval chain. 

Invion’s Chief Medical Officer, Dr Mitchell Glass, will be speaking at this event alongside Universal Biosensors MD & CEO, Mr Paul Wright.

The event will be held from 7.45am in The Long Room, Customs House, 399 Queen Street, Brisbane.

Further details of the event are available here: http://www.vision6.com.au/em/mail/view.php?id=1782537047&a=1643&k=c763f72


Posted in ASX Releases